More than 75 per cent of patients experience cognitive changes - known as 'chemo brain' - during treatment, with around 35 per cent reporting lingering symptoms years later.
A common cholesterol drug could prevent a debilitating side effect in cancer patients, a study has found.
More than 75 per cent of patients experience cognitive changes – known as 'chemo brain' – during treatment, with around 35 per cent reporting li... [1722 chars]